Last10K.com

Amerisourcebergen Corp (ABC) SEC Filing 10-K Annual Report for the fiscal year ending Friday, September 30, 2022

SEC Filings

ABC Annual Reports

Amerisourcebergen Corp

CIK: 1140859 Ticker: ABC

Exhibit 99.1
 
abcpress.jpg
abclogo.jpg
AmerisourceBergen Corporation
1 West First Avenue
Conshohocken, PA 19428
 

AMERISOURCEBERGEN REPORTS
FISCAL 2022 FOURTH QUARTER AND YEAR END RESULTS
Revenue of $61.2 Billion for the Fourth Quarter, a 3.8 Percent Year-Over-Year Increase
Fourth Quarter GAAP Diluted EPS of $1.40 and Adjusted Diluted EPS of $2.60
Revenue of $238.6 Billion for Fiscal Year 2022, an 11.5 Percent Year-Over-Year Increase
Fiscal Year 2022 GAAP Diluted EPS of $8.04 and Adjusted Diluted EPS of $11.03


 
CONSHOHOCKEN, PA, November 3, 2022
- AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent to $61.2 billion. Revenue increased 11.5 percent to $238.6 billion for the fiscal year. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $1.40 for the September quarter of fiscal 2022, compared to $2.08 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described below, increased 8.8 percent to $2.60 in the fiscal fourth quarter. For fiscal year 2022, diluted EPS increased 8.8 percent to $8.04. For fiscal year 2022, adjusted diluted EPS increased 19.1 percent to $11.03.

“AmerisourceBergen delivered strong performance in our 2022 fiscal year as our team’s execution excellence allowed us to deliver on our strategic priorities. Our leading capabilities in pharmaceutical distribution and manufacturer solutions enable us to play our core role in advancing pharmaceutical innovation and access,” said Steven H. Collis, Chairman, President & Chief Executive Officer of AmerisourceBergen.

“United by our purpose, our team members have positioned us well to execute on our long-term strategic vision of expanding our leadership in distribution while continuing to grow our higher-margin and higher-growth businesses,” Mr. Collis continued. “As we enter a new fiscal year, we are uniquely positioned to deliver long-term value creation to our stakeholders as we advance our foundation, enhance our capabilities, and invest in innovation to further drive our differentiation.”














The following information was filed by Amerisourcebergen Corp (ABC) on Thursday, November 3, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Amerisourcebergen Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Amerisourcebergen Corp.

Continue

Assess how Amerisourcebergen Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Amerisourcebergen Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
M & A
Revenue
Financial
Legal
Other
Filter Subcategory:
All
Product
Expense
Earnings
Shares
Income
Dividend
Debt
Geography
Cash Flow
Other
Inside Amerisourcebergen Corp's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Audit Information
Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flow
Consolidated Statements Of Changes In Stockholders' Equity
Consolidated Statements Of Changes In Stockholders' Equity (Parenthetical)
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Operations
Acquisition And Assets And Liabilities Held For Sale
Acquisition And Assets And Liabilities Held For Sale (Tables)
Acquisition And Assets And Liabilities Held For Sale - Additional Information (Details)
Acquisition And Assets And Liabilities Held For Sale - Assets And Liabilities (Details)
Acquisition And Assets And Liabilities Held For Sale - Assets And Liabilities Held For Sale (Details)
Acquisition And Assets And Liabilities Held For Sale - Fair Value Of Intangible Assets (Details)
Acquisition, Integration, And Restructuring Expenses
Acquisition, Integration, And Restructuring Expenses (Details)
Acquisition, Integration, And Restructuring Expenses (Tables)
Business Segment Information
Business Segment Information (Tables)
Business Segment Information - Additional Information (Details)
Business Segment Information - Reconciliation Of Segment Operating Income To Income From Continuing Operations (Details)
Business Segment Information - Segment Operating Income (Details)
Business Segment Information - Segment Revenue (Details)
Debt
Debt (Tables)
Debt - Additional Information (Details)
Debt - Debt Instruments (Details)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Details)
Goodwill And Other Intangible Assets
Goodwill And Other Intangible Assets (Tables)
Goodwill And Other Intangible Assets - Additional Information (Details)
Goodwill And Other Intangible Assets - Changes In Carrying Value Of Goodwill (Details)
Goodwill And Other Intangible Assets - Other Intangible Assets (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Details)
Income Taxes - Domestic And Foreign Income From Continuing Operations Before Income Taxes (Details)
Income Taxes - Income Tax Expense (Benefit) (Details)
Income Taxes - Reconciliation Of Effective Income Tax Rate (Details)
Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details)
Income Taxes - Significant Components Of Deferred Tax Liabilities (Assets) (Details)
Leases
Leases (Tables)
Leases - Future Minimum Rental Payments Under Noncancelable Operating Leases (Details)
Leases - Lease Cost (Details)
Leases - Other Information (Details)
Leases - Summary Of Balance Sheet Information Related To Leases (Details)
Legal Matters And Contingencies
Legal Matters And Contingencies (Details)
Litigation Settlements
Litigation Settlements (Details)
Related Party Transactions
Related Party Transactions (Details)
Retirement And Other Benefit Plans
Retirement And Other Benefit Plans (Details)
Schedule Ii????? Valuation And Qualifying Accounts
Schedule Ii????? Valuation And Qualifying Accounts (Details)
Share-Based Compensation
Share-Based Compensation (Tables)
Share-Based Compensation - Additional Information (Details)
Share-Based Compensation - Nonvested Options (Details)
Share-Based Compensation - Nonvested Performance Stock Units (Details)
Share-Based Compensation - Nonvested Restricted Stock Units (Details)
Share-Based Compensation - Stock Options (Details)
Share-Based Compensation - Weighted Average Assumptions (Details)
Stockholders' Equity And Weighted Average Common Shares Outstanding
Stockholders' Equity And Weighted Average Common Shares Outstanding (Tables)
Stockholders' Equity And Weighted Average Common Shares Outstanding - Additional Information (Details)
Stockholders' Equity And Weighted Average Common Shares Outstanding - Components Of Accumulated Other Comprehensive Loss (Details)
Stockholders' Equity And Weighted Average Common Shares Outstanding - Components Of Diluted Weighted Average Shares Outstanding (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Concentrations Of Credit Risk (Details)
Summary Of Significant Accounting Policies - Foreign Currency (Details)
Summary Of Significant Accounting Policies - Goodwill And Other Intangible Assets (Details)
Summary Of Significant Accounting Policies - Merchandise Inventories (Details)
Summary Of Significant Accounting Policies - Property And Equipment (Details)
Summary Of Significant Accounting Policies - Recently Adopted Accounting Pronouncements (Details)
Summary Of Significant Accounting Policies - Revenue Recognition (Details)
Summary Of Significant Accounting Policies - Schedule Of Property And Equipment (Details)
Summary Of Significant Accounting Policies - Schedule Of Restricted Cash (Details)
Summary Of Significant Accounting Policies - Shipping And Handling Costs (Details)
Variable Interest Entity
Variable Interest Entity (Tables)
Variable Interest Entity - Additional Information (Details)
Variable Interest Entity - Schedule Of Assets And Liabilities Of Profarma (Details)
Ticker: ABC
CIK: 1140859
Form Type: 10-K Annual Report
Accession Number: 0001140859-22-000098
Submitted to the SEC: Tue Nov 22 2022 3:54:05 PM EST
Accepted by the SEC: Tue Nov 22 2022
Period: Friday, September 30, 2022
Industry: Wholesale Drugs Proprietaries And Druggists Sundries

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/abc/0001140859-22-000098.htm